FrancophonIA/ELRC3.0 huggingface dataset:
English: Activyl 100 mg spot-on for dogs 1.5 - 6.5 kg Activyl 150 mg spot-on for dogs 6.6 - 10 kg Activyl 300 mg spot-on for dogs 10.1 - 20 kg Activyl 600 mg spot-on for dogs 20.1 - 40 kg Activyl 900 mg spot-on for dogs 40.1 - 60 kg indoxacarb
Danish: Activyl 100 mg spot-on til hunde 1,5 - 6,5 kg Activyl 150 mg spot-on til hunde 6,6 - 10 kg Activyl 300 mg spot-on til hunde 10,1 - 20 kg Activyl 600 mg spot-on til hunde 20,1 - 40 kg Activyl 900 mg spot-on til hunde 40,1 - 60 kg
English: PACKAGE LEAFLET Activyl spot-on solution for cats
Danish: INDLÆGSSEDDEL TIL: Activyl spot-on, opløsning, til katte
English: Ensure that the dosage (pipette) corresponds to the weight of the treated cat (see section 4.9).
Danish: Det skal sikres, at doseringen (pipetten) svarer til vægten af katten, der skal behandles (se pkt.
English: The veterinary product should not enter water courses.
Danish: Activyl må ikke udledes i vandløb.
English: Activyl 100 mg spot-on for cats ≤ 4 kg Activyl 200 mg spot-on for cats > 4 kg indoxacarb
Danish: Activyl 100 mg spot-on til katte ≤ 4 kg Activyl 200 mg spot-on til katte > 4 kg
English: Activyl 100 mg spot-on for very small dogs Activyl 150 mg spot-on for small dogs Activyl 300 mg spot-on for medium dogs Activyl 600 mg spot-on for large dogs Activyl 900 mg spot-on for extra large dogs indoxacarb
Danish: Activyl 100 mg spot-on til miniaturehunde Activyl 150 mg spot-on til små hunde Activyl 300 mg spot-on til mellemstore hunde Activyl 600 mg spot-on til store hunde Activyl 900 mg spot-on til ekstra store hunde
English: Apply to the skin only, at the base of the skull.
Danish: Kun til anvendelse på huden lige bag baghovedet.
English: Excipients:
Danish: Drægtighed:
English: Activyl 100 mg spot-on solution for small cats (≤ 4 kg) Activyl 200 mg spot-on solution for large cats (> 4 kg)
Danish: Activyl 100 mg spot-on, opløsning, til små katte (≤ 4 kg) Activyl 200 mg spot-on, opløsning, til store katte (> 4 kg)
English: In rare cases, application site reactions such as transitory scratching, erythema, alopecia or dermatitis at the application site may occur.
Danish: I sjældne tilfælde kan der forekomme reaktioner på applikationsstedet såsom forbigående kløe, erytem, alopeci eller dermatitis på applikationsstedet.
English: Apply the dose to an area where the cat cannot lick it off, as described in section 4.9.
Danish: 4.9 skal dosis administreres på et sted, hvor katten ikke kan komme til at slikke det af.
English: Correct application (see section 9) will minimise licking of the application site.
Danish: 9) vil minimere slikken på påføringsstedet.
English: Apply the dose to an area where the dog cannot lick it off, as described in section 4.9.
Danish: 4.9 skal dosis administreres på et sted, hvor hunden ikke kan komme til at slikke det af.
English: In very rare cases, application site reactions such as transitory scratching, erythema, alopecia or dermatitis at the application site may occur.
Danish: I meget sjældne tilfælde kan der forekomme reaktioner på applikationsstedet såsom forbigående kløe, erytem, alopeci eller dermatitis.
English: One unit-dose pipette delivers:
Danish: 1 enkeltdosispipette giver:
English: VIRBAC BELGIUM NV,
Danish: VIRBAC Österreich GmbH,
English: In very rare cases, application site reactions such as transitory scratching, erythema (redness of skin), alopecia (loss of hair) or dermatitis (inflammation of the skin) at the application site may occur.
Danish: Der kan i meget sjældne tilfælde forekomme reaktioner på påføringsstedet såsom forbigående kløe, erytem (hudrødme), alopeci (hårtab) eller dermatitis (betændelse i huden).
English: Maximum of 50
Danish: 1,03 Maksimum 50
English: In rare cases, application site reactions such as transitory scratching, erythema (redness of skin), alopecia (loss of hair) or dermatitis (inflammation of the skin) at the application site may occur.
Danish: Der kan i sjældne tilfælde forekomme reaktioner på påføringsstedet såsom forbigående kløe, erytem (hudrødme), alopeci (hårtab) eller dermatitis (betændelse i huden).
English: The major route of excretion is in faeces.
Danish: Udskillelse sker hovedsageligt via fæces.
English: Activyl 100 mg spot-on solution for small cats Activyl 200 mg spot-on solution for large cats
Danish: Activyl 100 mg spot-on til små katte Activyl 200 mg spot-on til store katte
English: The following table defines the size of pipette to be used according to the weight of the dog:
Danish: Nedenstående tabel angiver, hvilken størrelse pipette der skal bruges, afhængigt af hundens vægt:
English: Activyl 100 mg for very small dogs Activyl 150 mg for small dogs 10.1 - 20 Activyl 300 mg for medium dogs 20.1 - 40 Activyl 600 mg for large dogs 40.1 - 60 Activyl 900 mg for extra large dogs The appropriate combination of pipettes should be used
Danish: 1,5 - 6,5 Activyl 100 mg til miniaturehunde 6,6 - 10 Activyl 150 mg til små hunde 10,1 - 20 Activyl 300 mg til mellemstore hunde 20,1 - 40 Activyl 600 mg til store hunde 40,1 - 60 Activyl 900 mg til ekstra store hunde
English: Activyl 100 mg spot-on solution for very small dogs (1.5 - 6.5 kg) Activyl 150 mg spot-on solution for small dogs (6.6 - 10 kg) Activyl 300 mg spot-on solution for medium dogs (10.1 - 20 kg) Activyl 600 mg spot-on solution for large dogs (20.1 - 40 kg) Activyl 900 mg spot-on solution for extra large dogs (40.1 - 60 kg)
Danish: Activyl 100 mg spot-on, opløsning, til miniaturehunde (1,5 - 6,5 kg) Activyl 150 mg spot-on, opløsning, til små hunde (6,6-10 kg) Activyl 300 mg spot-on, opløsning, til mellemstore hunde (10,1-20 kg) Activyl 600 mg spot-on, opløsning, til store hunde (20,1-40 kg) Activyl 900 mg spot-on, opløsning, til ekstra store hunde (40,1-60 kg)
English: The following table defines the size of pipette to be used according to the weight of the cat:
Danish: Nedenstående tabel angiver, hvilken størrelse pipette der skal anvendes, afhængigt af kattens vægt:
English: In very rare cases, a brief period of hypersalivation (drooling) may occur if the cat licks the application site immediately after treatment.
Danish: I meget sjældne tilfælde er der observeret hypersalivation (øget spytsekretion/savlen) i en kortere periode, hvis katten umiddelbart efter behandling slikker på påføringsstedet.
English: In very rare cases, a brief period of hypersalivation (drooling) may occur if the animal licks the application site immediately after treatment.
Danish: I meget sjældne tilfælde kan der forekomme hypersalivation (øget spytsekretion/savlen) i en kortere periode, hvis dyret umiddelbart efter behandling slikker på påføringsstedet.
English: Activyl 100 mg spot-on for small cats Activyl 200 mg spot-on for large cats indoxacarb
Danish: Activyl 100 mg spot-on, opløsning, til små katte Activyl 200 mg spot-on, opløsning, til store katte Indoxacarb
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Danish: Særlige forholdsregler der skal træffes af personer, der administrerer lægemidlet til dyr: Opbevar pipetterne i den originale emballage indtil lige før brug.
English: Snap the tip open by bending it and folding it back on itself.
Danish: Åbn pipetten ved at bøje toppen af spidsen bagover og ned.
English: Pregnancy: Do not use during pregnancy.
Danish: Må ikke anvendes under drægtighed.
English: The following table defines the pipette to be used according to the weight of the dog:
Danish: Nedenstående tabel angiver, hvilken størrelse pipette der skal anvendes, afhængigt af hundens vægt:
English: Fertility: Do not use in breeding animals.
Danish: Må ikke anvendes til avlsdyr.
English: For adults with a weakened immune system (the body's natural defences), it is given for 10 days.
Danish: For voksne med et svækket immunsystem (kroppens naturlige forsvar) gives det i 10 dage.
English: Tamiflu received a marketing authorisation valid throughout the EU on 20 June 2002.
Danish: Tamiflu fik en markedsføringstilladelse med gyldighed i hele EU den 20. juni 2002.
English: Prevention of flu
Danish: Forebyggelse af influenza
English: When the neuramidases are blocked, the virus cannot spread.
Danish: Når neuraminidaserne blokeres, kan virusset ikke brede sig.
English: Treatment of flu
Danish: Behandling af influenza
English: Further information on Tamiflu can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/tamiflu.
Danish: Yderligere information om Tamiflu findes på agenturets websted under: ema.europa.eu/medicines/human/EPAR/tamiflu.
English: The studies measured the number of cases of flu proven by laboratory tests.
Danish: I studierne blev det målt, hvor mange tilfælde af influenza, der blev påvist ved laboratorieforsøg.
English: The average reduction in the duration of the illness in children aged 1 to 6 years was 1.5 days.
Danish: Den gennemsnitlige reduktion af sygdommens varighed hos børn i alderen 1-6 år var på 1,5 dage.
English: As for all medicines, data on the use of Tamiflu are continuously monitored.
Danish: Som for alle lægemidler bliver data vedrørende brug af Tamiflu løbende overvåget.
English: The medicine contains the active substance oseltamivir.
Danish: Lægemidlet indeholder det aktive stof oseltamivir.
English: It can also reduce the incidence of flu in patients who had come into contact with the disease or during a pandemic.
Danish: Det kan også reducere forekomsten af influenzatilfælde hos patienter, der har været i berøring med sygdommen, eller under en pandemi.
English: Effectiveness was measured by recording symptoms (feeling feverish, muscle pain, headache, sore throat, cough, overall discomfort and runny nose).
Danish: Virkningen blev målt ved at registrere symptomer (feber, muskelsmerter, hovedpine, ondt i halsen, hoste, generelt ubehag og løbende næse).
English: Tamiflu is available as capsules (30 mg, 45 mg, and 75 mg) and as a powder that is made up into a liquid to be drunk (6 mg/ml and 12 mg/ml).
Danish: Tamiflu fås som kapsler (30 mg, 45 mg og 75 mg) og som et pulver, der blandes til en væske, der drikkes (6 mg/ml og 12 mg/ml).
English: Tamiflu cannot replace flu vaccination, and its use should be based on official recommendations.
Danish: Tamiflu er ikke en erstatning for influenzavaccination, og dets anvendelse bør baseres på officielle anbefalinger.
English: For more information about using Tamiflu, see the package leaflet or contact your doctor or pharmacist.
Danish: For mere information om brug af Tamiflu, se indlægssedlen eller kontakt lægen eller apotekspersonalet.
English: Side effects reported with Tamiflu are carefully evaluated and any necessary action taken to protect patients.
Danish: Bivirkninger rapporteret for Tamiflu vurderes omhyggeligt, og der tages de nødvendige forholdsregler for at beskytte patienterne.
English: Other information about Tamiflu
Danish: Andre oplysninger om Tamiflu
English: What measures are being taken to ensure the safe and effective use of Tamiflu?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Tamiflu?
English: In adults, the duration of the illness was reduced from an average of 5.2 days for patients taking placebo, to 4.2 days for patients taking Tamiflu.
Danish: Hos voksne blev sygdommens varighed reduceret fra et gennemsnit på 5,2 dage for patienter, der tog placebo, til 4,2 dage for patienter, der tog Tamiflu.
English: Oseltamivir works on the neuramidases of both influenza A (the most common type) and influenza B viruses.
Danish: Oseltamivir virker på neuraminidaserne både ved influenza A-virus (den mest almindelige type) og influenza B-virus.
English: Side effects are generally mild or moderate in severity.
Danish: Bivirkningerne er generelt lette til moderate.
English: The European Medicines Agency decided that Tamiflu's benefits are greater than its risks and recommended that it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved Tamiflu opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: The active substance in Tamiflu, oseltamivir, acts on the flu virus, blocking some of the enzymes on its surface known as neuramidases.
Danish: Det aktive stof i Tamiflu, oseltamivir, virker på influenzavirusset ved at blokere visse enzymer på dets overflade kaldet neuraminidaser.
English: When Tamiflu is used during a flu epidemic, it is given for up to 6 weeks.
Danish: Når Tamiflu anvendes under en influenzaepidemi, gives det i op til seks uger.
English: The usual dose for adults and children weighing more than 40 kg is 75 mg given once a day for at least 10 days after contact with an infected person.
Danish: Den sædvanlige dosis for voksne og børn, der vejer over 40 kg, er 75 mg én gang dagligt i mindst 10 dage efter kontakt med en inficeret person.
English: A study also looked at using Tamiflu in a family setting (277 families) for both the treatment of the person with flu, and the treatment or prevention of flu in those in contact with the person.
Danish: I et studie kiggede man også på Tamiflu i en familiesituation (277 familier), hvor det blev brugt både til behandling af influenza og til behandling eller forebyggelse af influenza hos personer i berøring med den pågældende.
English: Tamiflu can also be used as preventative treatment in exceptional cases, for instance when the seasonal flu vaccine may not provide sufficient protection and when there is a pandemic (a global epidemic of flu).
Danish: Tamiflu kan undtagelsesvis anvendes som en forebyggende behandling, f.eks. når vaccinen mod sæsoninfluenza ikke er tilstrækkelig og ved et pandemiudbrud (en global influenzaepidemi).
English: Tamiflu reduced the incidence of flu in people who had come into contact with the disease when one of their family members contracted flu (962 cases) or during an epidemic (1,562 people aged between 16 and 65 years, and 548 elderly people in nursing homes).
Danish: Tamiflu reducerede forekomsten af influenza hos personer, der havde været i berøring med sygdommen, da et af deres familiemedlemmer fik influenza (962 tilfælde), eller under en epidemi (1 562 personer mellem 16 og 65 år og 548 ældre på plejehjem).
English: An overview of Tamiflu and why it is authorised in the EU
Danish: En oversigt over Tamiflu, og hvorfor det er godkendt i EU
English: In families with one patient who had flu, 7% of the family members in the household developed flu when receiving Tamiflu, compared with 20% of those receiving no preventative treatment.
Danish: I familier med én patient, der havde influenza, udviklede 7 % af familiemedlemmerne i husstanden influenza, når de fik Tamiflu, sammenholdt med 20 % af dem, der ikke modtog nogen forebyggende behandling.
English: Tamiflu reduced the duration of the illness compared with placebo (a dummy treatment) in several studies (involving 2,413 patients aged 13 years or over, 741 elderly patients aged 65 years or over and 1,033 children aged between 1 and 12 years).
Danish: Tamiflu reducerede varigheden af sygdommen sammenlignet med placebo (en virkningsløs behandling) i flere studier (der omfattede 2 413 patienter på 13 år eller derover, 741 ældre patienter på 65 år eller derover og 1 033 børn mellem 1 og 12 år).
English: Tamiflu is an antiviral medicine used to treat or prevent influenza (flu).
Danish: Tamiflu er et antiviralt lægemiddel, der anvendes til behandling eller forebyggelse af influenza.
English: • to treat flu, it can be used in adults and children (including full-term newborns) who have the symptoms of flu, when the flu virus is circulating in the community;
Danish: • Til behandling af influenza kan det anvendes hos voksne og børn (inklusive fuldbårne nyfødte) med symptomer på influenza, når der er influenzavirus i omløb i befolkningen.
English: Why is Tamiflu authorised in the EU?
Danish: Hvorfor blev Tamiflu godkendt i EU?
English: In the study carried out during an epidemic, 1% of the people taking Tamiflu developed flu after contact, compared with 5% of those taking placebo.
Danish: I det studie, der blev gennemført under en epidemi, udviklede 1 % af de personer, der tog Tamiflu, influenza, sammenlignet med 5 % af dem, der tog placebo.
English: What are the risks associated with Tamiflu?
Danish: Hvilke risici er der forbundet med Tamiflu?
English: What is Tamiflu and what it is used for?
Danish: Hvad er Tamiflu, og hvad anvendes det til?
English: For the full list of side effects and restrictions with Tamiflu, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger og begrænsninger ved Tamiflu fremgår af indlægssedlen.
English: • to prevent flu, it can be used in adults and children over 1 year of age who have been in contact with someone who has flu and flu is circulating in the community.
Danish: • Til forebyggelse af influenza kan det anvendes hos voksne og hos børn over ét år, der har været i berøring med en influenzaramt person, og når der er influenzavirus i omløb i befolkningen.
English: In children the most common side effects (seen in more than 1 patient in 10) are vomiting, cough and nasal congestion (a blocked nose).
Danish: Hos børn er de hyppigste bivirkninger (som optræder hos mere end 1 ud af 10 patienter) opkastning, hoste og tilstoppet næse.
English: When used for treatment of flu, Tamiflu reduces the duration of illness in adults and children.
Danish: Når Tamiflu anvendes til behandling for influenza, reducerer det sygdomsvarigheden hos voksne og børn.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Tamiflu have been included in the summary of product characteristics and the package leaflet.
Danish: Der er anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Tamiflu.
English: In the treatment of flu, Tamiflu must be started within two days of the onset of symptoms.
Danish: Behandlingen af influenza med Tamiflu skal påbegyndes senest to dage efter, at symptomerne er indtruffet.
English: During a flu pandemic, Tamiflu can also be used to prevent flu in babies below 1 year of age.
Danish: Under en influenzapandemi kan Tamiflu også anvendes til behandling eller forebyggelse hos spædbørn og småbørn under ét år.
English: In the prevention of flu, Tamiflu must be started within two days of contact with someone who has flu.
Danish: Den forebyggende behandling af influenza med Tamiflu skal påbegyndes senest to dage efter kontakt med en influenzaramt person.
English: The most common side effects with Tamiflu (seen in more than 1 patient in 10) in adults and adolescents are headache and nausea (feeling sick).
Danish: Hos voksne og unge er de hyppigste bivirkninger ved Tamiflu (som optræder hos mere end 1 ud af 10 patienter) hovedpine og kvalme.
English: How is Tamiflu used?
Danish: Hvordan anvendes Tamiflu?
English: What benefits of Tamiflu have been shown in studies?
Danish: Hvilke fordele viser studierne, at der er ved Tamiflu?
English: How does Tamiflu work?
Danish: Hvordan virker Tamiflu?
English: Aimovig received a marketing authorisation valid throughout the EU on 26 July 2018.
Danish: Aimovig fik en markedsføringstilladelse med gyldighed i hele EU den 26. juli 2018.
English: Further information on Aimovig can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/aimovig.
Danish: Yderligere information om Aimovig findes på agenturets websted under: ema.europa.eu/medicines/human/EPAR/aimovig.
English: EMA/CHMP/249688/2019 EMEA/H/C/004447
Danish: EMA/191978/2019 EMEA/H/C/004447
English: As for all medicines, data on the use of Aimovig are continuously monitored.
Danish: Som for alle lægemidler er data vedrørende brug af Aimovig løbende overvåget.
English: What is Aimovig and what is it used for?
Danish: Hvad er Aimovig, og hvad anvendes det til?
English: The recommended dose is 70 mg every 4 weeks as a single injection.
Danish: Den anbefalede dosis er 70 mg som en enkelt indsprøjtning hver fjerde uge.
English: An overview of Aimovig and why it is authorised in the EU
Danish: En oversigt over Aimovig og hvorfor det er godkendt i EU
English: The European Medicines Agency therefore decided that Aimovig's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede derfor, at fordelene ved Aimovig opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: Why is Aimovig authorised in the EU?
Danish: Hvorfor blev Aimovig godkendt i EU?
English: Some patients may benefit from a dose of 140 mg every 4 weeks, given as either a single injection of 140 mg or two injections of 70 mg.
Danish: Visse patienter kan have gavn af en dosis på 140 mg hver fjerde uge indgivet som enten én enkelt indsprøjtning på 140 mg eller to indsprøjtninger på 70 mg.
English: Other information about Aimovig
Danish: Andre oplysninger om Aimovig
English: For more information about using Aimovig, see the package leaflet or contact your doctor or pharmacist.
Danish: For mere information om brug af Aimovig, se indlægssedlen eller kontakt lægen eller apotekspersonalet.
English: The active substance in Aimovig, erenumab, is a monoclonal antibody (a type of protein) designed to attach to a receptor (target) for CGRP on body's cells.
Danish: Det aktive stof i Aimovig, erenumab, er et monoklonalt antistof (en type protein), der er designet til at binde sig til en receptor for CGRP på kroppens celler.
English: Side effects reported with Aimovig are carefully evaluated and any necessary action taken to protect patients.
Danish: Bivirkninger rapporteret for Aimovig vurderes omhyggeligt, og der foretages nødvendige forholdsregler for at beskytte patienterne.
English: Only patients with migraines at least 4 days a month were included in the studies as patients with less frequent migraines are not usually eligible for preventative treatment.
Danish: Kun patienter med migræne mindst fire dage om måneden indgik i studierne, da patienter med færre migræneanfald normalt ikke er egnede til forebyggende behandling.
English: Aimovig can only be obtained with a prescription and treatment should be started by a doctor experienced in the diagnosis and treatment of migraine.
Danish: Aimovig udleveres kun efter recept, og behandlingen bør iværksættes af en læge med erfaring i diagnosticering og behandling af migræne.
English: What measures are being taken to ensure the safe and effective use of Aimovig?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Aimovig?
English: The most common side effects with Aimovig (which may affect up to 1 in 10 people) are reactions at the site of injection, constipation, muscle spasms and itching.
Danish: De hyppigste bivirkninger ved Aimovig (der optræder hos op til 1 ud af 10 patienter) er reaktioner på injektionsstedet, forstoppelse, muskelspasmer og kløe.
English: By attaching to this receptor, the medicine stops CGRP from attaching to it and causing migraine.
Danish: Ved at binde sig til denne receptor forhindrer lægemidlet CGRP i at binde sig til receptoren og forårsage migræne.
English: Most of the side effects are mild or moderate in severity.
Danish: De fleste bivirkninger er lette til moderate.
English: Aimovig is a medicine used to prevent migraine in adults who have migraines at least 4 days a month.
Danish: Aimovig er et lægemiddel til forebyggelse af migræne hos voksne, der har migræne mindst fire dage om måneden.
English: What are the risks associated with Aimovig?
Danish: Hvilke risici er der forbundet med Aimovig?
English: Aimovig is injected under the skin using a pre-filled syringe or pen.
Danish: Aimovig indsprøjtes under huden med en fyldt sprøjte eller pen.
English: In a study of 667 patients who had migraines 18 days a month on average, those treated with Aimovig had 7 fewer days with migraines per month, compared with 4 fewer days for patients on placebo.
Danish: I et studie med 667 patienter, der led af migræne i gennemsnitligt 18 dage om måneden, havde de patienter, der fik Aimovig, syv færre dage med migræne om måneden sammenholdt med fire færre dage hos de patienter, der fik placebo.